158 results on '"Postelnick, Michael J"'
Search Results
2. Prospective Approach to Managing Antimicrobial Drug Shortages
3. The Impact of Anti-infective Drug Shortages on Hospitals in the United States: Trends and Causes
4. Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study
5. Decreasing incidence of Acinetobacter baumannii pneumonia and trends in antibiotic consumption: A single-center retrospective observational study
6. Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States
7. Antimicrobial Stewardship Practice in the Ambulatory Setting From a National Cohort
8. 803. Risk factors associated with Clostridioides difficile infection in hospitalized patients with community-acquired pneumonia
9. Clinical implications of antiretroviral drug interactions with warfarin: a case–control study
10. Decreasing incidence of Acinetobacter baumanniipneumonia and trends in antibiotic consumption: A single-center retrospective observational study
11. 453. Impact of antibiotic selection on risk-adjusted mortality in ICU patients requiring gram-negative therapy.
12. Effective use of a clinical decision-support system to advance antimicrobial stewardship
13. Low incidence of renal impairment observed in tenofovir-treated patients
14. Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19
15. Differences in Clinical Outcomes in Patients with Vancomycin-Resistant Enterococci According to Linezolid Susceptibility
16. The Impact of Qualitative Respiratory Cultures on Mortality in Critically Ill Patients With Hospital-Acquired Pneumonia
17. 2010. A Significant Reduction in Empiric Vancomycin Days of Therapy for Suspected MRSA Pneumonia in Adult Non-ICU Patients After Implementation of a Rapid MRSA Nasal PCR Test with Antimicrobial Stewardship Intervention
18. 2203. Patient-Specific Risk Stratification to Identify Patients at High and Low Risk for P. aeruginosa in Community-Acquired Pneumonia
19. Potential Impact of Vancomycin Pulmonary Distribution on Treatment Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia
20. Effect of on-call infectious-diseases pharmacists on antibiotic expenditures
21. Elevated Plasma Concentrations of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis B or C: Case Series and Literature Review
22. Antibiotic cost containment with “on-call” infectious diseases pharmacists as a side effect to enhanced patient care.: 173.
23. The Incidence of Antimicrobial Allergies in Hospitalized Patients: Implications Regarding Prescribing Patterns and Emerging Bacterial Resistance
24. Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR)
25. Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study
26. Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis
27. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation
28. Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmes
29. Prediction of inventory sustainability during a drug shortage
30. Diagnostic stewardship of C. difficiletesting: a quasi-experimental antimicrobial stewardship study
31. Impact of vancomycin treatment duration and dose on kidney injury
32. Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification
33. Successful Treatment of Extensively Drug-Resistant Acinetobacter baumannii Peritoneal Dialysis Peritonitis with Intraperitoneal Polymyxin B and Ampicillin-Sulbactam
34. Association of breast cancer in men with exposure to 5-α reductase inhibitors: A RADAR report.
35. Impact of Carbapenem Resistance and Receipt of Active Antimicrobial Therapy on Clinical Outcomes of Acinetobacter baumannii Bloodstream Infections
36. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients
37. Effect of Differences in MIC Values on Clinical Outcomes in Patients with Bloodstream Infections Caused by Gram-Negative Organisms Treated with Levofloxacin
38. Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption
39. Serum Piperacillin/Tazobactam Pharmacokinetics in a Morbidly Obese Individual
40. In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii
41. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci
42. Peritoneal Fluid Penetration of Tigecycline
43. Impact of Inactive Empiric Antimicrobial Therapy on Inpatient Mortality and Length of Stay
44. Potential Impact of Vancomycin Pulmonary Distribution on Treatment Outcomes in Patients with Methicillin-ResistantStaphylococcus aureusPneumonia
45. Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia
46. Breakthrough Candida Infections in Patients Receiving Voriconazole
47. Synergistic effect of gentamicin plus ampicillin on enterococci with differing sensitivity to gentamicin
48. The utility of aminoglycosides in an era of emerging drug resistance
49. Low incidence of renal impairment observed in tenofovir-treated patients.
50. Demystifying Kinetics: Establishment of an Aminoglycoside Clinical Pharmacokinetic Service
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.